Abigail Wexner Research Institute at Nationwide Children's Hospital
I received my Ph.D. in Biochemistry and Molecular Biology from the University of Strasbourg, France. I started working in the muscular dystrophy field in 2015 as a postdoctoral fellow under the mentorship of Dr. Scott Harper. I joined Dr. Harper's lab because of my interest in understanding dysregulation processes of gene expression in human diseases (i.e., FSHD), and because of my interest in working in a translational research setting in which I am determined to dedicate my career for the development of treatments for these diseases using gene therapy or drug-based therapy approaches. After joining Dr. Harper’s lab, I integrated an environment where many gene therapies are under development in the center for gene therapy under the lead of Dr. Mendell and Dr. Flanigan. Because of this environment, I acquired technical, design, planning and organizational skills required to take a gene therapy project from the first proof-of-principal steps to the implementation of the first pre-clinical studies. My ultimate goal is to develop novel therapeutic approaches to chronic diseases.